Can a virtual program boost development in kids with brain injuries?

NCT ID NCT06643598

Recruiting now Disease control Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a virtual version of the Abecedarian Approach, an early childhood education program, can help children ages 0-5 who had a brain injury from lack of oxygen (HIE) or were born very prematurely. Researchers will enroll 225 families and measure parent satisfaction and child development over time. The goal is to see if online delivery works as well as in-person programs, especially for families in rural areas.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Abecedarian Approach (behavioral education program delivered virtually)
What this could lead to: If it works, this could provide a scalable, virtual way to support early development in children with brain injuries or premature birth, especially in rural areas.
What could go wrong: This is a relatively small, early-stage behavioral study with no control group comparison yet. Results may not apply to all families, and virtual delivery may be less effective than in-person programs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain hypoxia - ischemia cerebral palsy nervous system disorder perinatal asphyxia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL PALSY HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE) NEUROLOGICAL DISORDER PREMATURE BIRTH

Contacts and locations

Locations

University of Wisconsin Madison
RECRUITING

Madison, Wisconsin, 53715, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.